Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Four leading healthcare academics in Oxford have received a prestigious national award.

© Shutterstock

The University of Oxford professors have been named National Institute of Health Research (NIHR) Senior Investigators in recognition of their “outstanding contribution to clinical and applied health and social care research”.

The successful candidates are all prominent researchers in the NIHR Oxford Biomedical Research Centre (BRC).

Together, the University of Oxford, Oxford Brookes University, Oxford University Hospitals NHS Foundation Trust and Oxford Health NHS Foundation Trust make up the Oxford Academic Health Science Centre (Oxford AHSC), a partnership that coordinates clinical and academic excellence across the partners.

Senior Investigators are appointed from NIHR Investigators through annual competitions, informed by the advice of an international panel of experts. In total, more than 300 Senior Investigators have now been appointed, with the number of active Senior Investigator awards maintained at around 200. They form part of the NIHR Faculty.

The new NIHR Senior Investigators are:

  • Professor Helen McShane, Director of the NIHR Oxford Biomedical Research Centre; Professor of Vaccinology, Nuffield Department of Medicine
  • Professor Ann Sarah Walker, Professor of Medical Statistics and Epidemiology, Nuffield Department of Medicine
  • Professor Matthew Costa, Professor of Orthopaedic Trauma, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences
  • Professor Richard McManus, Professor of Primary Care, Nuffield Department of Primary Care Health Sciences

As well as the new appointments, three professors who had previously held awards were designated Emeritus Senior Investigators.

Read more (NIHR Oxford BRC website)

Similar stories

Oxford announces the founding of the new Bennett Institute for Applied Data Science

The Bennett Institute for Applied Data Science at the University of Oxford has been established to pioneer the better use of data, evidence and digital tools in healthcare and policy, optimizing the impact of interventions to achieve improved outcomes.

Researchers develop machine learning algorithm to diagnose deep vein thrombosis

A team of researchers are developing the use of an artificial intelligence (AI) algorithm with the aim of diagnosing deep vein thrombosis (DVT) more quickly and as effectively as traditional radiologist-interpreted diagnostic scans, potentially cutting down long patient waiting lists and avoiding patients unnecessarily receiving drugs to treat DVT when they don’t have it.

COVID-19 recovery project nominated for HSJ award

The project, involving Oxford University Hospitals, Defence Medical Services (DMS), and the Radcliffe Department of Medicine is in the running for a prestigious honour at the Health Service Journal Awards 2021.

Oxford to assess revolutionary multi-cancer blood test in trial, for future implementation in the NHS

A partnership between the University of Oxford and GRAIL, LLC will evaluate the use of a new, non-invasive, multi-cancer early detection test known as Galleri in suspected cancer patients.

'Finding our Way: An NHS Tribute Garden' at RHS Chelsea Flower Show 2021

‘Finding Our Way – An NHS Tribute Garden’ is a celebration of the incredible efforts of the thousands of people who fought – and are still fighting - the COVID-19 pandemic on our behalf. The garden is designed by Naomi Ferrett-Cohen and presented by Oxford University Hospitals NHS Foundation Trust and Oxford University.